Oncotarget: Second line trastuzumab emtansine following horizontal dual blockade (AUDIO)

Impact Journals LLC

Caption

"From the 80s, Human Epidermal Growth Factor Receptor 2 (HER2) signaling was increasingly recognized as pivotal in tumor growth of HER2 expressing breast cancer. HER2 expression is limited to a proportion (15-20%) of breast cancer; however, HER2 conditions tumor behavior and addresses treatment strategies"

Credit

- DR. SALVATORE DEL PRETE, THE MEDICAL ONCOLOGY UNIT "SAN GIOVANNI DI DIO" HOSPITAL, FRATTAMAGGIORE & DR. LILIANA MONTELLA, THE MEDICAL ONCOLOGY UNIT "SANTA MARIA DELLE GRAZIE" HOSPITAL

Usage Restrictions

CCBY

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.